AIM: To evaluate attenuating properties of N-acetylcysteine (NAC) on oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis (NASH). METHODS: Male Sprague-Dawley rats were randomly divided into three groups. Group 1 (control, n=8) was free accessed to regular dry rat chow (RC) for 6 wk. Group 2 (NASH, n=8) was fed with 100% fat diet for 6 wk. Group 3 (NASH+NAC(20), n=9) was fed with 100% fat diet plus 20 mg/kg per day of NAC orally for 6 wk. All rats were sacrificed to collect blood and liver samples at the end of the study. RESULTS: The levels of total glutathione (GSH) and hepatic malondialdehyde (MDA) were increased significantly in the NASH group as compared with the control group (GSH; 2066.7+/-93.2 vs 1337.5+/-31.5 micromol/L and MDA; 209.9+/-43.9 vs 3.8+/-1.7 micromol/g protein, respectively, P<0.05). Liver histopathology from group 2 showed moderate to severe macrovesicular steatosis, hepatocyte ballooning, and necroinflammation. NAC treatment improved the level of GSH (1394.8+/-81.2 micromol/L, P<0.05), it did not affect MDA (150.1+/-27.0 micromol/g protein), but led to a decrease in fat deposition and necroinflammation. CONCLUSION: NAC treatment could attenuate oxidative stress and improve liver histology in rats with NASH.
AIM: To evaluate attenuating properties of N-acetylcysteine (NAC) on oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis (NASH). METHODS: Male Sprague-Dawley rats were randomly divided into three groups. Group 1 (control, n=8) was free accessed to regular dry rat chow (RC) for 6 wk. Group 2 (NASH, n=8) was fed with 100% fat diet for 6 wk. Group 3 (NASH+NAC(20), n=9) was fed with 100% fat diet plus 20 mg/kg per day of NAC orally for 6 wk. All rats were sacrificed to collect blood and liver samples at the end of the study. RESULTS: The levels of total glutathione (GSH) and hepatic malondialdehyde (MDA) were increased significantly in the NASH group as compared with the control group (GSH; 2066.7+/-93.2 vs 1337.5+/-31.5 micromol/L and MDA; 209.9+/-43.9 vs 3.8+/-1.7 micromol/g protein, respectively, P<0.05). Liver histopathology from group 2 showed moderate to severe macrovesicular steatosis, hepatocyte ballooning, and necroinflammation. NAC treatment improved the level of GSH (1394.8+/-81.2 micromol/L, P<0.05), it did not affect MDA (150.1+/-27.0 micromol/g protein), but led to a decrease in fat deposition and necroinflammation. CONCLUSION:NAC treatment could attenuate oxidative stress and improve liver histology in rats with NASH.
Authors: Richard Kirsch; Vivian Clarkson; Enid G Shephard; David A Marais; Mohamed A Jaffer; Vivienne E Woodburne; Ralph E Kirsch; Pauline de la M Hall Journal: J Gastroenterol Hepatol Date: 2003-11 Impact factor: 4.029
Authors: Indrani Sinha-Hikim; Amiya P Sinha-Hikim; Ruoqing Shen; Hyun Ju Kim; H Kim; Samuel W French; Nosratola D Vaziri; Nosratola D Vaziri; Albert C Crum; Albert Crum; Tripathi B Rajavashisth; Keith C Norris Journal: Exp Mol Pathol Date: 2011-05-03 Impact factor: 3.362
Authors: Tania E Schwingel; Caroline P Klein; Natalia F Nicoletti; Cristiana L Dora; Gabriela Hadrich; Cláudia G Bica; Tiago G Lopes; Vinicius Duval da Silva; Fernanda B Morrone Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2014-06-08 Impact factor: 3.000
Authors: Jonathan Jun; Vladimir Savransky; Ashika Nanayakkara; Shannon Bevans; Jianguo Li; Philip L Smith; Vsevolod Y Polotsky Journal: Am J Physiol Regul Integr Comp Physiol Date: 2008-08-13 Impact factor: 3.619
Authors: Mariana Verdelho Machado; Leandi Kruger; Mark L Jewell; Gregory Alexander Michelotti; Thiago de Almeida Pereira; Guanhua Xie; Cynthia A Moylan; Anna Mae Diehl Journal: Dig Dis Sci Date: 2015-09-24 Impact factor: 3.199
Authors: Hua Shen; Miao Li; Bingxuan Wang; Ian K Lai; Larry W Robertson; Gabriele Ludewig Journal: Environ Sci Pollut Res Int Date: 2013-05-04 Impact factor: 4.223
Authors: S Carbajo-Pescador; C Steinmetz; A Kashyap; S Lorenz; J L Mauriz; M Heise; P R Galle; J González-Gallego; S Strand Journal: Br J Cancer Date: 2012-12-20 Impact factor: 7.640
Authors: Luis Bujanda; Elizabeth Hijona; Mikel Larzabal; Marta Beraza; Pablo Aldazabal; Nerea García-Urkia; Cristina Sarasqueta; Angel Cosme; Belen Irastorza; Alberto González; Juan I Arenas Journal: BMC Gastroenterol Date: 2008-09-09 Impact factor: 3.067
Authors: Sayed H Seif El-Din; Naglaa M El-Lakkany; Abeer A El-Naggar; Olfat A Hammam; Hekma A Abd El-Latif; Afaf A Ain-Shoka; Fatma A Ebeid Journal: Res Pharm Sci Date: 2015 Jul-Aug